Annual Cash & Cash Equivalents:
$28.36M-$6.46M(-18.55%)Summary
- As of today, CLDX annual cash & cash equivalents is $28.36 million, with the most recent change of -$6.46 million (-18.55%) on December 31, 2024.
- During the last 3 years, CLDX annual cash & cash equivalents has fallen by -$10.79 million (-27.56%).
- CLDX annual cash & cash equivalents is now -83.26% below its all-time high of $169.40 million, reached on December 31, 2013.
Performance
CLDX Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$624.14M-$43.15M(-6.47%)Summary
- As of today, CLDX quarterly cash & cash equivalents is $624.14 million, with the most recent change of -$43.15 million (-6.47%) on June 30, 2025.
- Over the past year, CLDX quarterly cash & cash equivalents has dropped by -$173.38 million (-21.74%).
- CLDX quarterly cash & cash equivalents is now -23.81% below its all-time high of $819.15 million, reached on March 31, 2024.
Performance
CLDX Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CLDX Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -18.6% | -21.7% |
| 3Y3 Years | -27.6% | +75.5% |
| 5Y5 Years | +152.5% | +201.9% |
CLDX Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -27.6% | at low | -23.8% | +166.6% |
| 5Y | 5-Year | -35.3% | +152.5% | -23.8% | +281.2% |
| All-Time | All-Time | -83.3% | +1081.5% | -23.8% | >+9999.0% |
CLDX Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $624.14M(-6.5%) |
| Mar 2025 | - | $667.29M(-7.2%) |
| Dec 2024 | $28.36M(-18.6%) | $719.18M(-4.2%) |
| Sep 2024 | - | $750.70M(-5.9%) |
| Jun 2024 | - | $797.52M(-2.6%) |
| Mar 2024 | - | $819.15M(+94.2%) |
| Dec 2023 | $34.81M(+18.3%) | $421.70M(+80.1%) |
| Sep 2023 | - | $234.15M(-6.9%) |
| Jun 2023 | - | $251.40M(-9.5%) |
| Mar 2023 | - | $277.79M(-8.7%) |
| Dec 2022 | $29.43M(-24.8%) | $304.15M(-5.8%) |
| Sep 2022 | - | $322.77M(-9.3%) |
| Jun 2022 | - | $355.72M(-6.3%) |
| Mar 2022 | - | $379.67M(-6.7%) |
| Dec 2021 | $39.14M(-10.7%) | $406.95M(-3.6%) |
| Sep 2021 | - | $422.29M(+157.9%) |
| Jun 2021 | - | $163.74M(-6.8%) |
| Mar 2021 | - | $175.68M(-9.5%) |
| Dec 2020 | $43.84M(+290.3%) | $194.22M(-2.5%) |
| Sep 2020 | - | $199.29M(-3.6%) |
| Jun 2020 | - | $206.72M(+286.2%) |
| Mar 2020 | - | $53.52M(-16.6%) |
| Dec 2019 | $11.23M(-53.8%) | $64.18M(-11.7%) |
| Sep 2019 | - | $72.72M(-10.5%) |
| Jun 2019 | - | $81.24M(-4.4%) |
| Mar 2019 | - | $84.97M(-9.5%) |
| Dec 2018 | $24.31M(-39.7%) | $93.92M(-11.0%) |
| Sep 2018 | - | $105.52M(-7.3%) |
| Jun 2018 | - | $113.81M(-7.5%) |
| Mar 2018 | - | $123.05M(-11.6%) |
| Dec 2017 | $40.29M(-5.1%) | $139.13M(-0.8%) |
| Sep 2017 | - | $140.23M(-8.7%) |
| Jun 2017 | - | $153.58M(-7.8%) |
| Mar 2017 | - | $166.52M(-12.0%) |
| Dec 2016 | $42.46M(-41.1%) | $189.18M(-6.6%) |
| Sep 2016 | - | $202.55M(-8.0%) |
| Jun 2016 | - | $220.13M(-13.3%) |
| Mar 2016 | - | $254.02M(-12.4%) |
| Dec 2015 | $72.11M(+157.3%) | $289.89M(-4.5%) |
| Sep 2015 | - | $303.41M(-9.2%) |
| Jun 2015 | - | $333.99M(-6.8%) |
| Mar 2015 | - | $358.47M(+78.3%) |
| Dec 2014 | $28.02M(-83.5%) | $201.04M(-10.3%) |
| Sep 2014 | - | $224.08M(-11.2%) |
| Jun 2014 | - | $252.37M(-8.0%) |
| Mar 2014 | - | $274.23M(-9.5%) |
| Dec 2013 | $169.40M(+580.4%) | $302.98M(+121.8%) |
| Sep 2013 | - | $136.59M(-11.9%) |
| Jun 2013 | - | $154.98M(-15.0%) |
| Mar 2013 | - | $182.38M(+117.2%) |
| Dec 2012 | $24.90M(+109.2%) | $83.96M(+8.2%) |
| Sep 2012 | - | $77.61M(-1.3%) |
| Jun 2012 | - | $78.67M(-14.6%) |
| Mar 2012 | - | $92.13M(+46.8%) |
| Dec 2011 | $11.90M(-44.1%) | - |
| Sep 2011 | - | $62.77M(-11.9%) |
| Jun 2011 | - | $71.24M(+60.8%) |
| Mar 2011 | - | $44.31M(-23.2%) |
| Dec 2010 | $21.29M(-62.7%) | - |
| Sep 2010 | - | $57.66M(-12.4%) |
| Jun 2010 | - | $65.83M(-12.7%) |
| Mar 2010 | - | $75.37M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $57.00M(+28.8%) | - |
| Sep 2009 | - | $25.98M(-17.9%) |
| Jun 2009 | - | $31.63M(-25.9%) |
| Dec 2008 | $44.26M(+801.5%) | - |
| Sep 2008 | - | $42.70M(-18.5%) |
| Jun 2008 | - | $52.38M(+358.7%) |
| Mar 2008 | - | $11.42M(-27.1%) |
| Dec 2007 | $4.91M(-88.0%) | $15.66M(-66.5%) |
| Dec 2006 | $40.91M(+74.7%) | - |
| Sep 2006 | - | $46.68M(-12.7%) |
| Jun 2006 | - | $53.47M(-10.5%) |
| Mar 2006 | - | $59.76M(+555.9%) |
| Dec 2005 | $23.42M(-26.2%) | - |
| Dec 2004 | $31.74M(+56.7%) | - |
| Dec 2003 | $20.25M(-19.2%) | - |
| Dec 2002 | $25.07M(-41.2%) | - |
| Dec 2001 | $42.67M(-15.0%) | - |
| Dec 2000 | $50.18M(+268.4%) | - |
| Dec 1999 | $13.62M(+53.0%) | - |
| Jun 1999 | - | $9.11M(-17.2%) |
| Mar 1999 | - | $11.00M(+23.6%) |
| Dec 1998 | $8.90M(+39.1%) | $8.90M(+23.6%) |
| Sep 1998 | - | $7.20M(+38.5%) |
| Jun 1998 | - | $5.20M(-36.6%) |
| Mar 1998 | - | $8.20M(+28.1%) |
| Dec 1997 | $6.40M(-49.2%) | $6.40M(-24.7%) |
| Sep 1997 | - | $8.50M(-20.6%) |
| Jun 1997 | - | $10.70M(-12.3%) |
| Mar 1997 | - | $12.20M(-3.2%) |
| Dec 1996 | $12.60M(+2.4%) | $12.60M(-12.5%) |
| Sep 1996 | - | $14.40M(+114.9%) |
| Jun 1996 | - | $6.70M(-28.7%) |
| Mar 1996 | - | $9.40M(-23.6%) |
| Dec 1995 | $12.30M(+61.8%) | $12.30M(+98.4%) |
| Sep 1995 | - | $6.20M(-41.0%) |
| Jun 1995 | - | $10.50M(-18.6%) |
| Mar 1995 | - | $12.90M(+69.7%) |
| Dec 1994 | $7.60M(-73.1%) | $7.60M(-59.4%) |
| Sep 1994 | - | $18.70M(-10.1%) |
| Jun 1994 | - | $20.80M(-14.8%) |
| Mar 1994 | - | $24.40M(-13.8%) |
| Dec 1993 | $28.30M(+757.6%) | $28.30M(+133.9%) |
| Sep 1993 | - | $12.10M(-11.0%) |
| Jun 1993 | - | $13.60M(-12.8%) |
| Mar 1993 | - | $15.60M(-17.9%) |
| Dec 1992 | $3.30M(-85.1%) | - |
| Oct 1992 | - | $19.00M(-8.2%) |
| Jul 1992 | - | $20.70M(-6.3%) |
| Apr 1992 | - | $22.10M(-4.3%) |
| Apr 1992 | $22.10M(+154.0%) | - |
| Jan 1992 | - | $23.10M(-3.8%) |
| Oct 1991 | - | $24.00M(-5.9%) |
| Jul 1991 | - | $25.50M(+193.1%) |
| Apr 1991 | $8.70M(-23.0%) | $8.70M(+7.4%) |
| Jan 1991 | - | $8.10M(-12.9%) |
| Oct 1990 | - | $9.30M(-15.5%) |
| Jul 1990 | - | $11.00M(-2.7%) |
| Apr 1990 | $11.30M(+17.7%) | $11.30M(+56.9%) |
| Jan 1990 | - | $7.20M(-25.0%) |
| Apr 1989 | $9.60M(-11.1%) | $9.60M(-11.1%) |
| Apr 1988 | $10.80M(-20.0%) | $10.80M(-20.0%) |
| Apr 1987 | $13.50M(+462.5%) | $13.50M(+462.5%) |
| Apr 1986 | $2.40M | $2.40M |
FAQ
- What is Celldex Therapeutics, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Celldex Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Celldex Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of CLDX is $28.36M
What is the all-time high annual cash & cash equivalents for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high annual cash & cash equivalents is $169.40M
What is Celldex Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, CLDX annual cash & cash equivalents has changed by -$6.46M (-18.55%)
What is Celldex Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CLDX is $624.14M
What is the all-time high quarterly cash & cash equivalents for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $819.15M
What is Celldex Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, CLDX quarterly cash & cash equivalents has changed by -$173.38M (-21.74%)